INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 174 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24,234 | +116.7% | 62,298 | +148.7% | 0.00% | +200.0% |
| Q2 2023 | $11,185 | -48.5% | 25,049 | -5.5% | 0.00% | -50.0% |
| Q1 2023 | $21,736 | -49.1% | 26,508 | -3.2% | 0.00% | -60.0% |
| Q4 2022 | $42,711 | -99.9% | 27,379 | -2.8% | 0.01% | -16.7% |
| Q3 2022 | $48,602,000 | -6.3% | 28,175 | -6.0% | 0.01% | 0.0% |
| Q2 2022 | $51,878,000 | +61659.5% | 29,987 | +28.3% | 0.01% | -25.0% |
| Q1 2022 | $84,000 | -32.8% | 23,374 | -6.6% | 0.01% | -11.1% |
| Q4 2021 | $125,000 | -32.1% | 25,030 | -2.6% | 0.01% | -35.7% |
| Q3 2021 | $184,000 | -25.8% | 25,686 | -4.1% | 0.01% | -22.2% |
| Q2 2021 | $248,000 | +22.8% | 26,778 | +23.1% | 0.02% | +12.5% |
| Q1 2021 | $202,000 | – | 21,746 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Green Alpha Advisors, LLC | 570,049 | $221,749 | 0.17% |
| GMT CAPITAL CORP | 1,513,500 | $588,752 | 0.02% |
| Cedar Brook Financial Partners, LLC | 130,522 | $50,773 | 0.01% |
| Arlington Capital Management, Inc. | 27,735 | $10,789 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 296,948 | $116 | 0.01% |
| Keystone Financial Group | 109,897 | $42,751 | 0.01% |
| Hennion & Walsh Asset Management, Inc. | 163,562 | $63,626 | 0.00% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,149,974 | $447,340 | 0.00% |
| Freedom Investment Management, Inc. | 62,298 | $24,234 | 0.00% |
| Renaissance Technologies | 4,889,500 | $1,902 | 0.00% |